The company expired its plan on June 28, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,935 KRW | -1.63% | -1.75% | -3.79% |
1st Jan change | Capi. | |
---|---|---|
-3.79% | 26.7M | |
+20.75% | 7.21B | |
+7.58% | 3.69B | |
+28.99% | 2.35B | |
+87.42% | 2.34B | |
+10.26% | 2.34B | |
+5.21% | 2.29B | |
+4.20% | 1.75B | |
+32.46% | 1.68B | |
+7.62% | 1.67B |
- Stock Market
- Equities
- A318160 Stock
- News Cell Bio Human Tech Co., Ltd
- Cell Bio Human Tech Co., Ltd's Equity Buyback announced on March 26, 2024, has expired with 436,083 shares, representing 4.73% for KRW 1,819 million.